Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).
about
Oxygen therapy for acute myocardial infarctionNatriuretic peptides for acute heart failureNitrates for acute heart failure syndromesOxygen therapy for acute myocardial infarctionNatriuretic peptides for acute heart failureNitrates for acute heart failureGuidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologyOxygen therapy for acute myocardial infarction.Higher education is associated with reduced risk of heart failure among patients with acute myocardial infarction: A nationwide analysis using data from the CVDNOR project.Impact of chronic oral anticoagulation on management and outcomes of patients with acute myocardial infarction: data from the RICO survey.Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at riskDiabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity.Systemic Inflammatory Response Syndrome Predicts Mortality in Acute Coronary Syndrome without Congestive Heart Failure.The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.Assessment of left ventricular function in older Medicare beneficiaries with newly diagnosed heart failure.Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or bothOutcomes associated with comorbid atrial fibrillation and heart failure in Medicare beneficiaries with acute coronary syndrome.Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients.Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction.Acute and chronic impact of cardiovascular events on health state utilities.National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010.Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies.What can we learn from Europe?Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarctionAcute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry).Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.Prognostic Impact of In-Hospital and Postdischarge Heart Failure in Patients With Acute Myocardial Infarction: A Nationwide Analysis Using Data From the Cardiovascular Disease in Norway (CVDNOR) Project.Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective.Luteolin alleviates post-infarction cardiac dysfunction by up-regulating autophagy through Mst1 inhibitionNon ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.The cost of inpatient death associated with acute coronary syndrome.Aldosterone blockade in post-acute myocardial infarction heart failure.Profile of carvedilol controlled-release: a new once-daily formulation of carvedilol.Dynamic TIMI risk score for STEMI.Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction.Cost-effectiveness of eplerenone plus standard treatment compared with standard treatment in patients with myocardial infarction complicated by left ventricular systolic dysfunction and heart failure in the Netherlands.Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients From the Cardiovascular Disease in Norway (CVDNOR) Project.Long term prognosis of heart failure after acute coronary syndromes without ST elevation.Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failureParadoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II.
P2860
Q22252969-015D21EF-3418-4F19-A152-404DDF7975A8Q24194433-8791D5D5-A4AC-4DDC-8803-9EF0AC806830Q24200550-25F3DBF4-F5B2-4480-8A35-2A5DEFB895A6Q24234782-554FA1BA-3374-493C-B298-CDC6F17BF17AQ24245105-DA5D2578-9FE6-4992-A32F-2B9AB1981DCCQ24245410-7BA5020C-C26F-45A7-8956-75121330473EQ28239975-B26B06BE-7FE7-4172-A58B-7C450B25E3F9Q30240009-B228C22E-554E-489B-AC12-D3A42ADC6C31Q31115853-0C6126B9-FD9C-4D51-ACCE-8B1533FAE86CQ33230636-B9FC9DB2-8DDE-49FB-BCF9-595C238CB127Q33721171-9AF4C09A-91C8-48C5-8B82-FF847AAEFC06Q34230667-4A78E4C8-AB16-4AF6-BA91-5E396A1F2E0AQ34259243-F666DC47-4E61-49A1-A258-7A63F7968C9BQ34356918-6D927341-73C0-4FF1-A35D-F25C6759ED08Q34711207-42C62D4A-4D1D-4DD1-8303-448C142A98A8Q34823769-B5967F3D-AE1E-4254-9441-409FD3EBE28AQ35098660-2E8C184E-9ED5-4A42-B74E-D5B3D6E070CBQ35111496-0353E2AB-3E20-4B40-B06B-E3943248E100Q35149077-E66F3739-89CA-448B-B61A-DAF3F9DA0320Q35534337-F1115330-7A3E-430A-BD29-B7DD7751C6E1Q35556751-E7DAD2DA-213D-4ED4-82A1-A19A4B160CFBQ35772602-93717073-7E69-432E-AD77-9EC9C8F61E66Q35808277-6AC2F354-49DB-482B-AD9D-E704B09DB0FFQ35876377-664D015A-8D6D-4A60-A207-EAE1B44E6E1FQ36024237-CC50567D-FF9C-44E9-B5E8-A8159977B6AEQ36024246-B6A86389-47BF-41EB-9399-46677D256DBEQ36309695-AAE21B51-58C9-4366-BCE7-A2A8E00CC4AAQ36407129-C201E2AA-C0F9-40D3-B1E5-E41062018445Q36476858-02163C2D-F4E4-46BD-BBED-FF37FC429391Q36519924-AC772117-884B-40C4-A5A5-2DC0946E56DAQ36557658-DC42F985-8496-4CB5-93F5-E1B807C763B7Q36634189-3DA26174-D5F7-44AD-AB63-3B5C6AC96F0CQ36675404-25695A7E-6B41-440A-A26A-7D995802CA91Q36701761-A1D5D2ED-69C0-404D-B32B-5C7B314E5546Q36723119-7CBFB5F9-D47F-46E7-86E8-138D0AF111EEQ36813366-F46A0215-4F46-4769-9C91-348696CC0965Q36877727-51CC2510-8B60-4CA6-A936-A3C9279853D8Q36928252-A123DCB5-B3CE-4CE8-9505-31BD3B0F37B1Q37078756-F6D6A53A-150F-4DD9-891F-F197338143CCQ37119085-74590E56-D51D-47F7-B0A5-C3F1C1785728
P2860
Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Determinants and prognostic im ...... Acute Coronary Events (GRACE).
@en
Determinants and prognostic im ...... istry of Acute Coronary Events
@nl
type
label
Determinants and prognostic im ...... Acute Coronary Events (GRACE).
@en
Determinants and prognostic im ...... istry of Acute Coronary Events
@nl
prefLabel
Determinants and prognostic im ...... Acute Coronary Events (GRACE).
@en
Determinants and prognostic im ...... istry of Acute Coronary Events
@nl
P2093
P1433
P1476
Determinants and prognostic im ...... Acute Coronary Events (GRACE).
@en
P2093
Andrzej Budaj
Frederick A Anderson
Global Registry of Acute Coronary Events Investigators
José López-Sendón
Laurent J Feldman
Marie-Claude Aumont
Omar H Dabbous
Robert J Goldberg
Werner Klein
P304
P356
10.1161/01.CIR.0000109691.16944.DA
P407
P577
2004-01-26T00:00:00Z